Evotec SE (EVO) stock
EVONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as EVOTF
$1.58−0.08 (-4.82%)
Close on Nov 13, 2026Market cap $561.78MP/E –Yield –
Evotec total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Evotec's total debt was €81.50M at Dec 31, 2025. For fiscal 2025 it was €81.50M, up 200.6% from the year before. The highest annual figure on record is €362.48M in fiscal 2021.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €81.50M | +200.6% |
| FY2024 | Dec 31, 2024 | €27.11M | -79.1% |
| FY2023 | Dec 31, 2023 | €129.97M | -60.6% |
| FY2022 | Dec 31, 2022 | €329.85M | -9.0% |
| FY2021 | Dec 31, 2021 | €362.48M | +4.6% |
| FY2020 | Dec 31, 2020 | €346.41M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | €81.50M | -77.5% |
| Q4 FY2024 | Dec 31, 2024 | €27.11M | -92.2% |
| Q4 FY2023 | Dec 31, 2023 | €129.97M | – |
| Q4 FY2022 | Dec 31, 2022 | €329.85M | – |
| Q4 FY2021 | Dec 31, 2021 | €362.48M | – |
| Q4 FY2020 | Dec 31, 2020 | €346.41M | – |
See a number that looks wrong?